Mutations in CIITA or any of the four RFX regulatory genes (RFXANK, RFX5, and RFXAP) cause bare lymphocyte syndrome type II (BLSII), an immunodeficiency characterized by the lack of MHC class II expression. Here, CIITA is linked to MHC class II deficiency.